From mass vaccination to personalized vaccinology? The COVID-19 case

In recent times, especially as a result of the experience gained worldwide with the COVID19 pandemic vaccination campaigns, the personalization of vaccination strategies is becoming increasingly important. This does not yet mean bringing precision medicine and genomics approaches into immunization c...

Full description

Bibliographic Details
Main Authors: Andrea Silenzi, Antonio Vitiello, Giovanni Rezza
Format: Article
Language:English
Published: Istituto Superiore di Sanità 2023-12-01
Series:Annali dell'Istituto Superiore di Sanità
Online Access:https://annali.iss.it/index.php/anna/article/view/1613
_version_ 1797305165956513792
author Andrea Silenzi
Antonio Vitiello
Giovanni Rezza
author_facet Andrea Silenzi
Antonio Vitiello
Giovanni Rezza
author_sort Andrea Silenzi
collection DOAJ
description In recent times, especially as a result of the experience gained worldwide with the COVID19 pandemic vaccination campaigns, the personalization of vaccination strategies is becoming increasingly important. This does not yet mean bringing precision medicine and genomics approaches into immunization campaigns, but where there is more than one vaccine against the same disease, there is a need to identify criteria for personalizing vaccination. Vaccination strategies based on prescription appropriateness – whenever is possible – can lead to more effective immune response, reduced rates of adverse events, increased public confidence in vaccination and higher vaccination coverage, contributing to a decrease of morbidity and mortality related to preventable diseases.
first_indexed 2024-03-08T00:21:09Z
format Article
id doaj.art-983e61c1707f41a3b181bb4c33b3eaef
institution Directory Open Access Journal
issn 0021-2571
2384-8553
language English
last_indexed 2024-03-08T00:21:09Z
publishDate 2023-12-01
publisher Istituto Superiore di Sanità
record_format Article
series Annali dell'Istituto Superiore di Sanità
spelling doaj.art-983e61c1707f41a3b181bb4c33b3eaef2024-02-16T08:14:58ZengIstituto Superiore di SanitàAnnali dell'Istituto Superiore di Sanità0021-25712384-85532023-12-0159410.4415/ANN_23_04_021450From mass vaccination to personalized vaccinology? The COVID-19 caseAndrea Silenzi0Antonio VitielloGiovanni RezzaIstituto Superiore di SanitàIn recent times, especially as a result of the experience gained worldwide with the COVID19 pandemic vaccination campaigns, the personalization of vaccination strategies is becoming increasingly important. This does not yet mean bringing precision medicine and genomics approaches into immunization campaigns, but where there is more than one vaccine against the same disease, there is a need to identify criteria for personalizing vaccination. Vaccination strategies based on prescription appropriateness – whenever is possible – can lead to more effective immune response, reduced rates of adverse events, increased public confidence in vaccination and higher vaccination coverage, contributing to a decrease of morbidity and mortality related to preventable diseases.https://annali.iss.it/index.php/anna/article/view/1613
spellingShingle Andrea Silenzi
Antonio Vitiello
Giovanni Rezza
From mass vaccination to personalized vaccinology? The COVID-19 case
Annali dell'Istituto Superiore di Sanità
title From mass vaccination to personalized vaccinology? The COVID-19 case
title_full From mass vaccination to personalized vaccinology? The COVID-19 case
title_fullStr From mass vaccination to personalized vaccinology? The COVID-19 case
title_full_unstemmed From mass vaccination to personalized vaccinology? The COVID-19 case
title_short From mass vaccination to personalized vaccinology? The COVID-19 case
title_sort from mass vaccination to personalized vaccinology the covid 19 case
url https://annali.iss.it/index.php/anna/article/view/1613
work_keys_str_mv AT andreasilenzi frommassvaccinationtopersonalizedvaccinologythecovid19case
AT antoniovitiello frommassvaccinationtopersonalizedvaccinologythecovid19case
AT giovannirezza frommassvaccinationtopersonalizedvaccinologythecovid19case